Franklin M. Berger, Director at ESSA Pharma Inc. (EPIX), sold 388,680 shares at $2.86 ($1.0M) on 2022-12-15, disclosed to the SEC on 2023-01-05.
Open-market sale of $1.0M EPIX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.00 | 25,000 | $75K | 7.4% |
| 2 | $2.86 | 50,000 | $143K | 14.1% |
| 3 | $2.90 | 32,000 | $93K | 9.2% |
| 4 | $2.67 | 50,000 | $134K | 13.2% |
| 5 | $2.53 | 43,617 | $110K | 10.9% |
| 6 | $2.53 | 43,617 |
| $110K |
| 10.9% |
| 7 | $2.41 | 37,889 | $91K | 9.0% |
| 8 | $2.41 | 37,889 | $91K | 9.0% |
| 9 | $2.42 | 34,334 | $83K | 8.2% |
| 10 | $2.42 | 34,334 | $83K | 8.2% |
| Total | $2.61 avg | 388,680 | $1.0M | 100% |
| Filing → |
| EPIX | BUY | 2023-11-22 | $267K | — | Filing → |
| EPIX | BUY | 2023-11-16 | $518K | — | Filing → |
| RAIN | BUY | 2022-11-23 | $988K | — | Filing → |